These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 19067495

  • 1. Are patent expirations the answer to improving patient adherence?
    Klepser DG.
    Am J Manag Care; 2008 Dec; 14(12):787-8. PubMed ID: 19067495
    [No Abstract] [Full Text] [Related]

  • 2. Lowering copayments: impact of simvastatin patent expiration on patient adherence.
    Sedjo RL, Cox ER.
    Am J Manag Care; 2008 Dec; 14(12):813-8. PubMed ID: 19067498
    [Abstract] [Full Text] [Related]

  • 3. Pharmaceutical patent settlements: the antitrust risks.
    Balto DA.
    Food Drug Law J; 2000 Dec; 55(3):321-41. PubMed ID: 11824464
    [No Abstract] [Full Text] [Related]

  • 4. Pharmaceutical policy in Italy: towards a structural change?
    Ghislandi S, Krulichova I, Garattini L.
    Health Policy; 2005 Apr; 72(1):53-63. PubMed ID: 15760698
    [Abstract] [Full Text] [Related]

  • 5. Action alert: drug-patent bill could cost patients $3 billion+; hearing July 1.
    AIDS Treat News; 1999 Jun 18; (No 321):8. PubMed ID: 11366716
    [Abstract] [Full Text] [Related]

  • 6. A generic problem.
    Hanauer SB.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec 18; 3(12):649. PubMed ID: 17130869
    [No Abstract] [Full Text] [Related]

  • 7. Generics battle brand names over mortality of drug patents.
    Betz R.
    J Healthc Resour Manag; 1995 Jul 18; 13(7):35-7. PubMed ID: 10144008
    [No Abstract] [Full Text] [Related]

  • 8. Five drugs facing key patent expirations and potential generic entry from April to May 2020.
    Friedman Y.
    Pharm Pat Anal; 2020 May 18; 9(2):41-43. PubMed ID: 32314664
    [Abstract] [Full Text] [Related]

  • 9. Patent watch.
    Harrison C.
    Nat Rev Drug Discov; 2013 Jan 18; 12(1):14-5. PubMed ID: 23274462
    [No Abstract] [Full Text] [Related]

  • 10. Drug costs threaten patent protection.
    Cimons M.
    Nat Med; 2003 Jan 18; 9(1):9. PubMed ID: 12514706
    [No Abstract] [Full Text] [Related]

  • 11. Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering.
    Paine CS.
    Seton Hall Law Rev; 2003 Jan 18; 33(2):479-510. PubMed ID: 12715807
    [No Abstract] [Full Text] [Related]

  • 12. How companies stall generics and keep themselves healthy.
    Stolberg SG, Gerth J.
    N Y Times Web; 2000 Jul 23; ():A1, A14, A15. PubMed ID: 11785519
    [No Abstract] [Full Text] [Related]

  • 13. Protect pharmaceutical innovation.
    Musselwhite LW, Andrews J.
    Science; 2010 Jun 11; 328(5984):1354; author reply 1354-5. PubMed ID: 20538934
    [No Abstract] [Full Text] [Related]

  • 14. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ, Graham SJ.
    Science; 2009 Oct 16; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract] [Full Text] [Related]

  • 15. The effect of Paragraph IV decisions and generic entry before patent expiration on brand pharmaceutical firms.
    Panattoni LE.
    J Health Econ; 2011 Jan 16; 30(1):126-45. PubMed ID: 21074873
    [Abstract] [Full Text] [Related]

  • 16. Overcoming the challenges in the pharma/biotech industry.
    Graul AI, Prous JR.
    Drug News Perspect; 2007 Jan 16; 20(1):57-68. PubMed ID: 17332900
    [Abstract] [Full Text] [Related]

  • 17. Branded drug reformulation: the next brand vs. generic antitrust battleground.
    Amoresano GV.
    Food Drug Law J; 2007 Jan 16; 62(1):249-56. PubMed ID: 17444032
    [No Abstract] [Full Text] [Related]

  • 18. US policy may encourage counterfeit drugs.
    Bouchie A.
    Nat Biotechnol; 2003 Feb 16; 21(2):121. PubMed ID: 12560826
    [No Abstract] [Full Text] [Related]

  • 19. Drug patent protection: how long is long enough?
    Sibbald B.
    CMAJ; 2001 May 01; 164(9):1331. PubMed ID: 11341146
    [No Abstract] [Full Text] [Related]

  • 20. AIDS drugs. Brazil, Thailand override big pharma patents.
    Cohen J.
    Science; 2007 May 11; 316(5826):816. PubMed ID: 17495145
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.